StockData
AYTUNasdaqPharmaceutical PreparationsFiscal year ends June 30

AYTU BIOPHARMA, INC

Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Sep 22, 2026
$1.96−0.08 (-3.92%)

Close on Oct 19, 2026

Market cap
$37.82M
P/E (TTM)
–
Dividend yield
–

Price history

Daily open, high, low, close and volume

DateOpenHighLowCloseChangeVolume
Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected.

Stock splits

From SEC filings

DateRatioEffect on per-share figures
Jan 6, 20231-for-20 reverseEarlier per-share figures multiplied by 20
Jan 6, 20231-for-20 reverseEarlier per-share figures multiplied by 20
Feb 11, 2021(first seen in filings)1-for-10 reverseEarlier per-share figures multiplied by 10
Dec 9, 20201-for-10 reverseEarlier per-share figures multiplied by 10
Nov 7, 2018(first seen in filings)1-for-20 reverseEarlier per-share figures multiplied by 20
Aug 13, 20181-for-20 reverseEarlier per-share figures multiplied by 20
Aug 31, 2017(first seen in filings)1-for-20 reverseEarlier per-share figures multiplied by 20
Aug 29, 20171-for-20 reverseEarlier per-share figures multiplied by 20
Sep 1, 2016(first seen in filings)1-for-12 reverseEarlier per-share figures multiplied by 12
Jul 1, 20161-for-12 reverseEarlier per-share figures multiplied by 12
Sep 28, 2015(first seen in filings)1-for-5.67 reverseEarlier per-share figures multiplied by 5.6667